Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
5
×
biotech
boston blog main
boston top stories
life sciences
national blog main
national top stories
new york blog main
new york top stories
novartis
5
×
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
fda
microbiome
pfizer
abbvie
abeona therapeutics
alnylam pharmaceuticals
astrazeneca
avexis
biontech
brian kaspar
What
roundup
bio
drug
biotech
brings
fda
new
news
according
acquire
acquisitions
advantages
agreed
akcea
august
bar
biggest
billion
build
busy
buy
cases
cash
centers
ceo
cholesterol
cigarettes
company
company’s
compound
control
daniel
days
deal
deaths
debut
decisions
devices
disease
drugs
Language
unset
5
×
Current search:
unset
×
novartis
×
amgen
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More